Free Trial
→ Trump’s EO to send this $5 stock ripping higher…? (From Traders Agency) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$61.16
+1.0%		$68.94
$38.91
▼
$147.03
$1.75B0.67699,525 shs574,396 shs
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$20.07
+14.6%		$17.40
$12.26
▼
$29.65
$1.22B1.592.60 million shs4.40 million shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover
7 Blue-Chip Stocks to Add To Your Forever Portfolio

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
0.00%-4.56%-12.76%+6.82%-32.69%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
0.00%+18.69%+21.49%-11.66%+11.13%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$61.16
+1.0%		$68.94
$38.91
▼
$147.03
$1.75B0.67699,525 shs574,396 shs
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$20.07
+14.6%		$17.40
$12.26
▼
$29.65
$1.22B1.592.60 million shs4.40 million shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover
7 Blue-Chip Stocks to Add To Your Forever Portfolio

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
0.00%-4.56%-12.76%+6.82%-32.69%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
0.00%+18.69%+21.49%-11.66%+11.13%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
2.05
Hold$71.2416.47% Upside
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2.43
Hold$27.1835.45% Upside

Current Analyst Ratings Breakdown

Latest TNDM and INSP Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/12/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeHold (C-) ➝ Sell (D+)
11/6/2026
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Mizuho logo
Mizuho
Subscribe to MarketBeat All Access to unlock brokerage rankings
Set Price Target$20.00
11/6/2026
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetEqual Weight$18.00 ➝ $20.00
11/6/2026
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetOverweight$27.00 ➝ $25.00
11/3/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingHold$78.00 ➝ $76.00
11/3/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetEqual Weight$56.00 ➝ $69.00
11/3/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
JPMorgan Chase & Co. logo
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetNeutral$60.00 ➝ $65.00
11/3/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetUnderweight$65.00 ➝ $62.00
11/3/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Robert W. Baird logo
Robert W. Baird
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetNeutral$73.00 ➝ $77.00
11/3/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetNeutral$60.00 ➝ $70.00
10/28/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeSell (D+) ➝ Hold (C-)
(Data available from 11/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$911.98M1.94$2.89 per share21.14$28.55 per share2.14
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$1.01B1.38N/AN/A$1.94 per share10.35
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$145.42M$3.4417.7840.504.4311.43%7.32%6.39%N/A
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$204.71M-$0.72N/AN/AN/A-4.58%-35.61%-4.53%N/A

Latest TNDM and INSP Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/5/2026Q3 2026
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$0.2453-$0.1020+$0.1433-$0.1020$265.85 million$283.69 million
11/2/2026Q3 2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$0.0870$0.14+$0.0530-$0.84$204.31 million$206.70 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
N/AN/AN/AN/AN/A
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
N/A
6.45
4.61
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
4.47
3.20
2.65

Institutional Ownership

CompanyInstitutional Ownership
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
94.91%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
N/A

Insider Ownership

CompanyInsider Ownership
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
2.20%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
1,33328.97 million28.33 millionOptionable
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2,50069.79 million68.33 millionOptionable

Recent News About These Companies

Tandem Diabetes Care, Inc. Receives FDA Clearance for Tandem Mobi Tubeless Automated Insulin Delivery System
November 14 at 7:49 AM  |  marketscreener.comM
Tandem Diabetes Care (NASDAQ:TNDM) Stock Crosses Above 200 Day Moving Average - Should You Sell?
November 14 at 3:22 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31197874
Tandem Diabetes Care (NASDAQ:TNDM) Stock Price Crosses Above 200 Day Moving Average - Time to Sell?
November 14 at 3:19 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-tandem-diabetes-care-nasdaq-tndm-stock-price-crosses-above-200-day-moving-average-time-to-sell-2026-11-14/
Tandem Diabetes Care Shares Gain on FDA Clearance for Tubeless Insulin Delivery System
November 13 at 7:50 PM  |  marketscreener.comM
Tandem Diabetes Care Shares Rise After Obtaining US FDA Clearance for Tubeless Automated Insulin Delivery System
November 13 at 7:50 PM  |  marketscreener.comM
Tandem Diabetes stock trades up, here is why
November 13 at 7:50 PM  |  msn.comhttps://www.msn.com/en-us/news/other/tandem-diabetes-stock-trades-up-here-is-why/ar-AA2hngDk
Tandem Diabetes Care jumps 12% on FDA clearance for tubeless Mobi
November 13 at 7:50 PM  |  seekingalpha.comhttps://seekingalpha.com/news/4672417-tandem-diabetes-care-jumps-12-percent-on-fda-clearance-for-tubeless-mobi
Tandem Diabetes stock jumps 8% on FDA clearance for tubeless pump
November 13 at 7:50 PM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/tandem-diabetes-stock-jumps-8-151136631.html
Tandem Mobi Becomes Only Insulin Pump Offering Both Tubed and Tubeless Wear Options
November 13 at 1:50 PM  |  benzinga.comhttps://www.benzinga.com/news/fda/26/11/63259329/tandem-mobi-becomes-only-insulin-pump-offering-both-tubed-and-tubeless-wear-options
Tandem Mobi Becomes Only Insulin Pump Offering Both Tubed and Tubeless Wear Options
November 13 at 1:30 PM  |  benzinga.comhttps://www.benzinga.com/news/fda/26/11/63259329/tandem-mobi-becomes-only-insulin-pump-offering-both-tubed-and-tubeless-wear-options?utm_source=snapi
Tandem Diabetes Care (NASDAQ:TNDM) Shares Gap Up - Time to Buy?
November 13 at 10:59 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-tandem-diabetes-care-nasdaq-tndm-shares-gap-up-time-to-buy-2026-11-13/
Tandem Diabetes Care Receives Health Canada Approvals For t:slim X2 Insulin Pump With Control-IQ+ Technology
November 13 at 9:48 AM  |  marketscreener.comM
Tandem Mobi Now FDA Cleared as World’s First and Only Tubeless AID System with up to Seven Days of Wear
November 13 at 9:48 AM  |  marketscreener.comM
Can Tandem Diabetes Care (TNDM) Stay Cheap After Its Recall?
November 13 at 9:48 AM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/tandem-diabetes-care-tndm-stay-091008899.html
Tandem Diabetes Care Receives FDA Clearance for Tandem Mobi
November 13 at 9:11 AM  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/tandem-diabetes-care-receives-fda-clearance-for-tandem-mobi?utm_source=marketbeat.com&utm_medium=referral
Tandem Diabetes Care Gets Health Canada Approval for Expanded t:slim X2 Use
November 12 at 1:38 PM  |  marketscreener.comM
Tandem Diabetes Care Receives Multiple Health Canada Approvals for t:slim X2 Insulin Pump
November 12 at 8:38 AM  |  marketscreener.comM
Tandem Diabetes Care, Inc. 2026 Q3 - Results - Earnings Call Presentation
November 10, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4966098-tandem-diabetes-care-inc-2026-q3-results-earnings-call-presentation
Tandem Diabetes Care (NASDAQ:TNDM) Price Target Raised to $20.00
November 9, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31187145
Tandem Diabetes Care (NASDAQ:TNDM) Stock Gets Price Target Cut from Wells Fargo & Company
November 9, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31187138
Can Tandem Diabetes Care (TNDM) Justify Its Valuation As Q3 Earnings Beat And CEO Change Land?
November 8, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/tandem-diabetes-care-tndm-justify-201434653.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Inspire Medical Systems stock logo

Inspire Medical Systems NYSE:INSP

$61.16 +0.62 (+1.03%)
Closing price 11/13/2026 03:59 PM Eastern
Extended Trading
$59.89 -1.28 (-2.08%)
As of 11/13/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Tandem Diabetes Care stock logo

Tandem Diabetes Care NASDAQ:TNDM

$20.07 +2.56 (+14.62%)
Closing price 11/13/2026 04:00 PM Eastern
Extended Trading
$19.74 -0.32 (-1.62%)
As of 11/13/2026 07:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas